Sept 22 (Reuters) – Filana Therapeutics, Inc.: * FILANA THERAPEUTICS ANNOUNCES FDA LIFT OF CLINICAL HOLD ON SIMUFILAM, ENABLING PHASE 2A STUDY IN TSC-RELATED EPILEPSY * FILANA THERAPEUTICS, – FDA
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: TENERIFE SOCCER CLUB PAYING TRIBUTE TO STRIKER JESUS DE MIGUEL AT STADIUM /…
IRAN STATE TV REPORTER SAYS EXPLOSIONS MAY BE LINKED TO IRANIAN MILITARY'S ACTIVITIES IN STRAIT…
VIDEO SHOWS: BARCELONA HOLD TRAINING SESSION AND BARCELONA COACH HANSI FLICK HOLDS PRESS CONFERENCE AHEAD…
CARDIFF, Nov 7 (Reuters) - Wales coach Steve Tandy has admitted there is no hiding…
Nov 7 (Stats Perform) - Results from the NCAAF games on Saturday (home team in…
VIDEO SHOWS: HIGHLIGHTS OF BEN SHELTON BEATING LUCA VAN ASSCHE IN THE PARIS MASTERS SEMI-FINALS…